Finance

Beta
Lists
NXTG:TLV
Nextage Therapeutics Ltd
ILA 44.00
-2.65%
(-1.20) 1D
May 28, 5:27:41 PM GMT+3  ·   ILA
All symbols
SymbolPriceChange% Change
Generating top insights for NXTG...
Open
ILA 45.20
Mkt. cap
41.74M
Avg. vol.
95.87K
Volume
0.00
P/E ratio
43.31
52-wk high
ILA 107.00
52-wk low
ILA 30.00
EPS
ILA 0.01
Shares outstanding
94.86M
No. of employees
31
Open
ILA 45.20
Mkt. cap
41.74M
Avg. vol.
95.87K
Volume
0.00
P/E ratio
43.31
52-wk high
ILA 107.00
52-wk low
ILA 30.00
EPS
ILA 0.01
Shares outstanding
94.86M
No. of employees
31
News stories
From sources across the web
About Nextage Therapeutics Ltd
CEO-
Employees31
Founded1982
Headquarters-
SectorBiotechnology
Previous reportsAll values in ILS
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in ILS
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
52.00K
52.00K
677.00K
677.00K
Cost of goods sold
36.50K
36.50K
755.50K
755.50K
Cost of revenue
36.50K
36.50K
755.50K
755.50K
Research and development expenses
43.50K
43.50K
344.50K
344.50K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
786.00K
786.00K
940.00K
940.00K
Operating expense
829.50K
829.50K
1.28M
1.28M
Total operating expenses
866.00K
866.00K
2.04M
2.04M
Operating income
-814.00K
-814.00K
-1.36M
-1.36M
Other non operating income
-1.82M
-1.82M
-
-
EBT including unusual items
-2.64M
-2.64M
571.00K
571.00K
EBT excluding unusual items
-2.64M
-2.64M
-1.99M
-1.99M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.50M
-2.50M
678.00K
678.00K
Net profit margin
-4,808.65%
-4,808.65%
100.15%
100.15%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-12.00K
-12.00K
-609.00K
-609.00K
Net interest expenses
-12.00K
-12.00K
-609.00K
-609.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-801.17K
-807.50K
-1.04M
-1.04M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more